Canada Life’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.9M Sell
91,816
-268,742
-75% -$17.7M 0.01% 680
2025
Q4
$22.5M Sell
360,558
-4,401
-1% -$270K 0.04% 345
2025
Q3
$21.8M Sell
364,959
-1,955
-0.5% -$114K 0.03% 411
2025
Q2
$21M Buy
366,914
+46,082
+14% +$2.47M 0.03% 406
2025
Q1
$16.3M Sell
320,832
-99,631
-24% -$5.04M 0.03% 453
2024
Q4
$20.1M Sell
420,463
-60,256
-13% -$3.03M 0.03% 414
2024
Q3
$25.4M Sell
480,719
-15,355
-3% -$781K 0.04% 355
2024
Q2
$24.5M Buy
496,074
+14,984
+3% +$746K 0.05% 349
2024
Q1
$24.2M Sell
481,090
-33,126
-6% -$1.6M 0.05% 345
2023
Q4
$24.4M Sell
514,216
-2,994
-0.6% -$134K 0.05% 328
2023
Q3
$22.5M Sell
517,210
-8,987
-2% -$411K 0.05% 328
2023
Q2
$24.4M Buy
526,197
+26,902
+5% +$1.24M 0.06% 318
2023
Q1
$22.6M Buy
499,295
+92,030
+23% +$4.1M 0.06% 329
2022
Q4
$17.2M Buy
407,265
+83,141
+26% +$3.37M 0.05% 399
2022
Q3
$11.7M Sell
324,124
-20,795
-6% -$847K 0.03% 472
2022
Q2
$14.1M Sell
344,919
-125,909
-27% -$5.6M 0.04% 453
2022
Q1
$22.6M Buy
470,828
+31,878
+7% +$1.55M 0.05% 372
2021
Q4
$22.3M Buy
438,950
+53,009
+14% +$2.72M 0.05% 390
2021
Q3
$19.6M Buy
385,941
+40,890
+12% +$2.13M 0.05% 398
2021
Q2
$17.8M Buy
345,051
+43,034
+14% +$2.22M 0.04% 429
2021
Q1
$14.8M Buy
302,017
+69,669
+30% +$3.4M 0.04% 466
2020
Q4
$11M Buy
232,348
+65,177
+39% +$2.87M 0.02% 587
2020
Q3
$6.87M Buy
167,171
+38,784
+30% +$1.59M 0.01% 632
2020
Q2
$4.99M Buy
128,387
+69,041
+116% +$2.52M 0.01% 693
2020
Q1
$2.01M Sell
59,346
-39,668
-40% -$1.59M 0.01% 947
2019
Q4
$4.32M Sell
99,014
-11,609
-10% -$495K 0.01% 757
2019
Q3
$4.56M Buy
110,623
+8,336
+8% +$340K 0.01% 693
2019
Q2
$4.26M Buy
102,287
+63,460
+163% +$2.62M 0.01% 794
2019
Q1
$1.58M Sell
38,827
-54,750
-59% -$2.19M ﹤0.01% 1183
2018
Q4
$3.49M Buy
93,577
+35,861
+62% +$1.42M 0.01% 754
2018
Q3
$2.5M Sell
57,716
-29,530
-34% -$1.27M 0.01% 1025
2018
Q2
$3.75M Buy
87,246
+34,691
+66% +$1.55M 0.01% 822
2018
Q1
$2.32M Sell
52,555
-26,367
-33% -$1.2M 0.01% 1050
2017
Q4
$3.53M Sell
78,922
-37,264
-32% -$1.65M 0.01% 832
2017
Q3
$5.01M Buy
116,186
+20,539
+21% +$871K 0.01% 694
2017
Q2
$3.94M Sell
95,647
-2,338
-2% -$95.3K 0.01% 771
2017
Q1
$3.86M Buy
97,985
+92,005
+1,539% +$3.53M 0.01% 771
2016
Q4
$219K Buy
5,980
+511
+9% +$18.6K ﹤0.01% 1891
2016
Q3
$205K Buy
+5,469
New +$201K ﹤0.01% 1900

Other funds holding VEA

Canada Life's VEA Position: Q1 2026 in Review

Canada Life reduced its Vanguard FTSE Developed Markets ETF (VEA) stake by 75% in Q1 2026, selling an estimated $17.7M and leaving 91,816 shares worth $5.9M. The position accounts for 0.01% of the portfolio, ranked #680.

Canada Life first reported a position in VEA in Q3 2016 and has held it in 39 quarters since. The position peaked at $25.4M in Q3 2024. 2,894 funds tracked by Wall St. Rank hold VEA as of Q1 2026.

  • Canada Life held 91,816 shares of Vanguard FTSE Developed Markets ETF worth $5.9M as of Q1 2026.
  • Canada Life sold 268,742 Vanguard FTSE Developed Markets ETF shares in Q1 2026, an estimated $17.7M.
  • Vanguard FTSE Developed Markets ETF made up 0.01% of Canada Life's portfolio in Q1 2026, its #680 holding.
  • Canada Life first reported a position in Vanguard FTSE Developed Markets ETF in Q3 2016 and has held it in 39 quarters since.
  • Canada Life's Vanguard FTSE Developed Markets ETF position peaked at $25.4M in Q3 2024.
  • 2,894 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.